VAN HEUVELEN STRATEGIES, LLC for ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 325 Continuing Resolution; S. Con. Res. 8, FY 2014 Budget Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD New | Chief of Staff to Senator Jeff Bingaman |
Health Issues HCR
Prescription drug user fee act and other issues related to generic drugs; H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 2295 Patient Safety and Generic Labeling Improvement Act; H.R. 3204 The Drug Quality and Security Act; S. 1720 Patent Transparency and Improvements Act of 2013; H.R. 3309 Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD New | Chief of Staff to Senator Jeff Bingaman |
Labor Issues/Antitrust/Workplace LBR
Issues related to patent settlements and patent reform; S. 214 Preserve Access to Affordable Generics Act; S. 1720 Patent Transparency and Improvements Act of 2013; H.R. 3309 Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD New | Chief of Staff to Senator Jeff Bingaman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.